Starting from the use of insulin, the research progress in improving the pharmacotherapy of diabetes, through the discovery of metformin, sulfonylureas, and thiazolidinediones, failed to reduce cardiovascular events despite the beneficial effects on blood glucose regulation [5]. Here, INS is linked to diabetes mellitus.